Cases & Deals

Funds managed by Invesco invest in Cell Medica

Clients Invesco Asset Management Limited

Jones Day advised Invesco Asset Management in connection with the purchase by its discretionary managed funds of Series C Convertible Preferred Stock in a private placement by Cell Medica, a leading cellular immunotherapy company. Touchstone Innovations and funds managed by Woodford Investment Management acted as co-investors in the investment round.